Samsung BioLogics Co (XKRX:207940) Research & Development : ₩155,347 Mil (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Samsung BioLogics Co's Research & Development for the three months ended in Mar. 2025 was ₩35,273 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ₩155,347 Mil.

Samsung BioLogics Co Research & Development Historical Data

The historical data trend for Samsung BioLogics Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co Research & Development Chart

Samsung BioLogics Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Research & Development

Get a 7-Day Free Trial

5,105.83

954.22

45,883.75

81,587.99

144,648.96

Samsung BioLogics Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Research & Development	Get a 7-Day Free Trial															24,574.55	26,580.72	29,617.09	63,876.60	35,272.93

Samsung BioLogics Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩155,347 Mil.

Samsung BioLogics Co (XKRX:207940) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Samsung BioLogics Co Research & Development Related Terms

Thank you for viewing the detailed overview of Samsung BioLogics Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Samsung BioLogics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

125, Cheomdan-daero, Yeonsu-gu, Incheon, KOR

Website

https://www.samsungbiologics.com

Founded in 2011, Samsung Biologics is a South Korean contract development and manufacturing organization with a global client base. Europe and the US contribute 90% of its total revenue. It provides end-to-end development and manufacturing services from cell line developments to final commercial manufacturing. As of 2023, Samsung Biologics had a total production capacity of 604,000 liters, one of the largest in the world. Its CDMO services account for 72.4% of its total revenue. The balance comes from subsidiary Samsung Bioepis, acquired in 2022. Samsung Bioepis is involved in developing and manufacturing biosimilars.

Samsung BioLogics Co Headlines

No Headlines